Ali, M. U., Sherifali, D., Fitzpatrick‐Lewis, D., Kenny, M., Lamarche, L., Raina, P., & Mangin, D. (2022). Interventions to address polypharmacy in older adults living with multimorbidity. Canadian Family Physician, 68(7), e215–e226.
https://doi.org/10.46747/cfp.6807e215
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology of multi1780morbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet, 380(9836), 37–43.
https://doi.org/10.1016/s0140-6736(12)60240-2
Bungard, T. J., Yakiwchuk, E., Foisy, M., & Brocklebank, C. (2011). Drug interactions involving Warfarin: practice tool and practical management tips. Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada, 144(1), 21-25.e9.
https://doi.org/10.3821/1913-701x-144.1.21
Campanelli, C. M. (2012). American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 60(4), 616–631.
https://doi.org/10.1111/j.1532-5415.2012.03923.x
Chan, D. K. Y. (2021). Chan's practical geriatrics, Forth Edition.
Du Vaure, C. B., Ravaud, P., Baron, G., Barnes, C., Gilberg, S., & Boutron, I. (2016). Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysis. BMJ Open, 6(3), e010119.
https://doi.org/10.1136/bmjopen-2015-010119
Edwards, I. R., & Aronson, J. K. (2000). Adverse drug reactions: definitions, diagnosis, and management. The Lancet, 356(9237), 1255–1259.
https://doi.org/10.1016/s0140-6736(00)02799-9
Hilmer, S. N., Gnjidic, D., & Couteur, D. G. L. (2012). Thinking through the medication list - appropriate prescribing and deprescribing in robust and frail older patients. PubMed, 41(12), 924–928.
https://pubmed.ncbi.nlm.nih.gov/23210113
Hines, L., & Murphy, J. E. (2011). Potentially Harmful Drug–Drug Interactions in the Elderly: A review. American Journal of Geriatric Pharmacotherapy, 9(6), 364–377.
https://doi.org/10.1016/j.amjopharm.2011.10.004
Lam, M. P. Y., & Cheung, B. (2012). The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population. Expert Review of Clinical Pharmacology, 5(2), 187–197.
https://doi.org/10.1586/ecp.12.6
Lam, T., & Chan, H. (2017). The Hong Kong Geriatrics Society Curriculum in Geriatric Medicine, 2nd edition, Chapter 15 (pp. 114-125). The Hong Kong Geriatrics Society.
Lindblad, C. I., Hanlon, J. T., Gross, C. R., Sloane, R., Pieper, C. F., Hajjar, E. R., Ruby, C. M., Schmader, K. E., & Panel, M. C. (2006). Clinically important drug-disease interactions and their prevalence in older adults. Clinical Therapeutics, 28(8), 1133–1143.
https://doi.org/10.1016/j.clinthera.2006.08.006
Mallet, L., Spinewine, A., & Huang, A. (2007). The challenge of managing drug interactions in elderly people. The Lancet, 370(9582), 185–191.
https://doi.org/10.1016/s0140-6736(07)61092-7
Nobili, A., Garattini, S., & Mannucci, P. M. (2011). Multiple Diseases and Polypharmacy in the elderly: Challenges for the Internist of the third Millennium. Journal of Comorbidity, 1(1), 28–44. https://doi.org/10.15256/joc.2011.1.4
Reeve, E., Gnjidic, D., Long, J. C., & Hilmer, S. N. (2015). A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice. British Journal of Clinical Pharmacology, 80(6), 1254–1268.
https://doi.org/10.1111/bcp.12732
Seppälä, L., Petrovic, M., Ryg, J., Bahat, G., Topinková, E., Szczerbińska, K., Van Der Cammen, T. J. M., Hartikainen, S., İlhan, B., Landi, F., Morrissey, Y., Mair, A., Gutiérrez-Valencia, M., Emmelot‐Vonk, M. H., Mora, M. Á. C., Denkinger, M., Crome, P., Jackson, S., Correa-Pérez, A., . . . Van Der Velde, N. (2021). STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age And Ageing, 50(4), 1189–1199.
https://doi.org/10.1093/ageing/afaa249
Sheppard, J. P., Burt, J., Lown, M., Temple, E., Lowe, R., Fraser, R., Allen, J., Ford, G. A., Heneghan, C., Hobbs, F. D. R., Jowett, S., Kodabuckus, S., Little, P., Mant, J., Mollison, J., Payne, R., Williams, M., Yu, L., & McManus, R. J. (2020). Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older. JAMA, 323(20), 2039.
https://doi.org/10.1001/jama.2020.4871
Somkrua, R., Eickman, E. E., Saokaew, S., Lohitnavy, M., & Chaiyakunapruk, N. (2011). Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. BMC Medical Genetics, 12(1).
https://doi.org/10.1186/1471-2350-12-118
Woodford, H. J., & Fisher, J. (2019). New horizons in deprescribing for older people. Age And Ageing, 48(6), 768–775.
https://doi.org/10.1093/ageing/afz109
Woodward, M. (2003). Deprescribing: Achieving Better Health Outcomes for Older People through Reducing Medications. Journal of Pharmacy Practice and Research, 33(4), 323–328.
https://doi.org/10.1002/jppr2003334323
Wong, C. F., Chiu, P. K. C., & Chu, L. W. (2005). Zopiclone withdrawal: an unusual cause of delirium in the elderly. Age And Ageing, 34(5), 526–527.
https://doi.org/10.1093/ageing/afi132
Ali, M. U., Sherifali, D., Fitzpatrick‐Lewis, D., Kenny, M., Lamarche, L., Raina, P., & Mangin, D. (2022). Interventions to address polypharmacy in older adults living with multimorbidity. Canadian Family Physician, 68(7), e215–e226. https://doi.org/10.46747/cfp.6807e215
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology of multi1780morbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet, 380(9836), 37–43. https://doi.org/10.1016/s0140-6736(12)60240-2
Bungard, T. J., Yakiwchuk, E., Foisy, M., & Brocklebank, C. (2011). Drug interactions involving Warfarin: practice tool and practical management tips. Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada, 144(1), 21-25.e9. https://doi.org/10.3821/1913-701x-144.1.21
Campanelli, C. M. (2012). American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 60(4), 616–631. https://doi.org/10.1111/j.1532-5415.2012.03923.x
Chan, D. K. Y. (2021). Chan's practical geriatrics, Forth Edition.
Du Vaure, C. B., Ravaud, P., Baron, G., Barnes, C., Gilberg, S., & Boutron, I. (2016). Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysis. BMJ Open, 6(3), e010119. https://doi.org/10.1136/bmjopen-2015-010119
Edwards, I. R., & Aronson, J. K. (2000). Adverse drug reactions: definitions, diagnosis, and management. The Lancet, 356(9237), 1255–1259. https://doi.org/10.1016/s0140-6736(00)02799-9
Hilmer, S. N., Gnjidic, D., & Couteur, D. G. L. (2012). Thinking through the medication list - appropriate prescribing and deprescribing in robust and frail older patients. PubMed, 41(12), 924–928. https://pubmed.ncbi.nlm.nih.gov/23210113
Hines, L., & Murphy, J. E. (2011). Potentially Harmful Drug–Drug Interactions in the Elderly: A review. American Journal of Geriatric Pharmacotherapy, 9(6), 364–377. https://doi.org/10.1016/j.amjopharm.2011.10.004
Lam, M. P. Y., & Cheung, B. (2012). The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population. Expert Review of Clinical Pharmacology, 5(2), 187–197. https://doi.org/10.1586/ecp.12.6
Lam, T., & Chan, H. (2017). The Hong Kong Geriatrics Society Curriculum in Geriatric Medicine, 2nd edition, Chapter 15 (pp. 114-125). The Hong Kong Geriatrics Society.
Lindblad, C. I., Hanlon, J. T., Gross, C. R., Sloane, R., Pieper, C. F., Hajjar, E. R., Ruby, C. M., Schmader, K. E., & Panel, M. C. (2006). Clinically important drug-disease interactions and their prevalence in older adults. Clinical Therapeutics, 28(8), 1133–1143. https://doi.org/10.1016/j.clinthera.2006.08.006
Mallet, L., Spinewine, A., & Huang, A. (2007). The challenge of managing drug interactions in elderly people. The Lancet, 370(9582), 185–191. https://doi.org/10.1016/s0140-6736(07)61092-7
Nobili, A., Garattini, S., & Mannucci, P. M. (2011). Multiple Diseases and Polypharmacy in the elderly: Challenges for the Internist of the third Millennium. Journal of Comorbidity, 1(1), 28–44. https://doi.org/10.15256/joc.2011.1.4
Reeve, E., Gnjidic, D., Long, J. C., & Hilmer, S. N. (2015). A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice. British Journal of Clinical Pharmacology, 80(6), 1254–1268. https://doi.org/10.1111/bcp.12732
Seppälä, L., Petrovic, M., Ryg, J., Bahat, G., Topinková, E., Szczerbińska, K., Van Der Cammen, T. J. M., Hartikainen, S., İlhan, B., Landi, F., Morrissey, Y., Mair, A., Gutiérrez-Valencia, M., Emmelot‐Vonk, M. H., Mora, M. Á. C., Denkinger, M., Crome, P., Jackson, S., Correa-Pérez, A., . . . Van Der Velde, N. (2021). STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age And Ageing, 50(4), 1189–1199. https://doi.org/10.1093/ageing/afaa249
Sheppard, J. P., Burt, J., Lown, M., Temple, E., Lowe, R., Fraser, R., Allen, J., Ford, G. A., Heneghan, C., Hobbs, F. D. R., Jowett, S., Kodabuckus, S., Little, P., Mant, J., Mollison, J., Payne, R., Williams, M., Yu, L., & McManus, R. J. (2020). Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older. JAMA, 323(20), 2039. https://doi.org/10.1001/jama.2020.4871
Somkrua, R., Eickman, E. E., Saokaew, S., Lohitnavy, M., & Chaiyakunapruk, N. (2011). Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. BMC Medical Genetics, 12(1). https://doi.org/10.1186/1471-2350-12-118
Woodford, H. J., & Fisher, J. (2019). New horizons in deprescribing for older people. Age And Ageing, 48(6), 768–775. https://doi.org/10.1093/ageing/afz109
Woodward, M. (2003). Deprescribing: Achieving Better Health Outcomes for Older People through Reducing Medications. Journal of Pharmacy Practice and Research, 33(4), 323–328. https://doi.org/10.1002/jppr2003334323
Wong, C. F., Chiu, P. K. C., & Chu, L. W. (2005). Zopiclone withdrawal: an unusual cause of delirium in the elderly. Age And Ageing, 34(5), 526–527. https://doi.org/10.1093/ageing/afi132
Chui, M. A., Pohjanoksa-Mäntylä, M., & Snyder, M. E. (2019). Improving medication safety in varied health systems. Research in Social and Administrative Pharmacy. https://doi.org/10.1016/j.sapharm.2019.04.012
Gil-Candel, M., Solana‐Altabella, A., Vicente-Escrig, E., Puplá-Bartoll, A., Azuara, J. B., Pérez-Huertas, P., & Piqueres, R. F. (2023). Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results. European Journal of Hospital Pharmacy, 30(2), 107–112. https://doi.org/10.1136/ejhpharm-2021-003194
Hänninen, K., Ahtiainen, H. K., Suvikas-Peltonen, E., & Tötterman, A. M. (2023). Automated unit dose dispensing systems producing individually packaged and labelled drugs for inpatients: a systematic review. European Journal of Hospital Pharmacy, 30(3), 127–135. https://doi.org/10.1136/ejhpharm-2021-003002
Jafarzadeh, A., Mahboub‐Ahari, A., Najafi, M., Yousefi, M., & Dalal, K. (2021). Medicine storage, wastage, and associated determinants among urban households: a systematic review and meta-analysis of household surveys. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-11100-4
Kavanagh, O. N., Courtenay, A. J., Khan, F., & Lowry, D. (2022). Providing pharmaceutical care remotely through medicines delivery services in community pharmacy. Exploratory Research in Clinical and Social Pharmacy, 8, 100187. https://doi.org/10.1016/j.rcsop.2022.100187
Lee, S., & Schommer, J. C. (2022). Medication use and storage, and their potential risks in US households. Pharmacy, 10(1), 27. https://doi.org/10.3390/pharmacy10010027
Mash, R., Schouw, D., Daviaud, E., Besada, D., & Roman, D. (2022). Evaluating the implementation of home delivery of medication by community health workers during the COVID-19 pandemic in Cape Town, South Africa: a convergent mixed methods study. BMC Health Services Research, 22(1). https://doi.org/10.1186/s12913-022-07464-x
Mulac, A., Mathiesen, L., Taxis, K., & Granås, A. G. (2021). Barcode medication administration technology use in hospital practice: a mixed-methods observational study of policy deviations. BMJ Quality & Safety, 30(12), 1021–1030. https://doi.org/10.1136/bmjqs-2021-013223
Santos, Y. S., De Souza Ferreira, D., De Oliveira Silva, A. B. M., Da Silva Nunes, C. F., De Souza Oliveira, S. A., & Da Silva, D. T. (2023). Global overview of pharmacist and community pharmacy actions to address COVID-19: A scoping review. Exploratory Research in Clinical and Social Pharmacy, 10, 100261. https://doi.org/10.1016/j.rcsop.2023.100261